Patients who continue to have symptoms despite PPI therapy are considered to have refractory GERD, usually defined as the persistence of typical symptoms unresponsive to steady doses of PPIs twice daily. days for at least 12 weeks of treatment. Up to 30% of GERD patients have treatment-resistant GERD.

Patients who continue to have symptoms despite PPI therapy are considered to have refractory GERD, usually defined as the persistence of typical symptoms unresponsive to steady doses of PPIs twice daily. days for at least 12 weeks of treatment. Up to 30% of GERD patients have treatment-resistant GERD.

Patients who continue to have symptoms despite PPI therapy are considered to have refractory GERD, usually defined as the persistence of typical symptoms unresponsive to steady doses of PPIs twice daily. days for at least 12 weeks of treatment. Up to 30% of GERD patients have treatment-resistant GERD.

Eosinophilic esophagitis (eosinophilic esophagitis) is a chronic, immune-mediated disease caused by food allergens, presenting with symptoms of dysfunction. esophagitis and esophagitis dominated by eosinophils.

Eosinophilic esophagitis (EoE) is a chronic, immunological or antigenic esophageal disorder that is clinically characterized by symptoms of esophageal dysfunction and histologically by invasion infiltration of eosinophils in the esophageal epithelium.

Eosinophilic esophagitis (eosinophilic esophagitis) is a chronic, immune-mediated disease caused by food allergens, presenting with symptoms of dysfunction. esophagitis and esophagitis dominated by eosinophils. Recent consensus guidelines now include proton pump inhibitor therapy as an alternative first-line treatment. This review will discuss why proton pump inhibitors are currently being used as a first-line treatment strategy.

Eosinophilic esophagitis (eosinophilic esophagitis) is a chronic, immune-mediated disease caused by food allergens, presenting with symptoms of dysfunction. esophagitis and esophagitis dominated by eosinophils.

Helicobacter pylori is the main cause of stomach ulcers and many other diseases. Currently, there are many methods to treat H. Accordingly, antacids prescribed to treat this disease have also yielded many good results.

Thuốc kháng tiết axit là liệu pháp điều trị đầu tay cho các rối loạn thực quản như viêm thực quản trào ngược, viêm thực quản ăn mòn và thực quản của Barrett. Hoạt động cơ học chính của PPI là giảm sản xuất axit ở dạ dày bằng cách ức chế bơm hydro-kali ATPase - một protein xuyên màng chịu trách nhiệm giải phóng axit clohydric vào lòng dạ dày.